Group One Trading’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4
| Closed | -$2 | – | 8209 |
|
|
2025
Q1 | $2 | Buy |
4
+2
| +100% | +$19 | ﹤0.01% | 7468 |
|
|
2024
Q4 | $39 | Hold |
2
| – | – | ﹤0.01% | 7129 |
|
|
2024
Q3 | $56 | Hold |
2
| – | – | ﹤0.01% | 6496 |
|
|
2024
Q2 | $91 | Sell |
2
-5
| -71% | -$369 | ﹤0.01% | 6555 |
|
|
2024
Q1 | $844 | Hold |
7
| – | – | ﹤0.01% | 6666 |
|
|
2023
Q4 | $1.11K | Hold |
7
| – | – | ﹤0.01% | 6971 |
|
|
2023
Q3 | $1.69K | Sell |
7
-1
| -13% | -$373 | ﹤0.01% | 7090 |
|
|
2023
Q2 | $4.33K | Sell |
8
-5
| -38% | -$3.07K | ﹤0.01% | 6782 |
|
|
2023
Q1 | $10.2K | Sell |
13
-11
| -46% | -$8.13K | ﹤0.01% | 5921 |
|
|
2022
Q4 | $7.3K | Sell |
24
-2
| -8% | -$845 | ﹤0.01% | 6165 |
|
|
2022
Q3 | $13K | Hold |
26
| – | – | ﹤0.01% | 6335 |
|
|
2022
Q2 | $15K | Sell |
26
-22
| -46% | -$18.3K | ﹤0.01% | 6506 |
|
|
2022
Q1 | $62K | Buy |
48
+8
| +20% | +$8.84K | ﹤0.01% | 5934 |
|
|
2021
Q4 | $46K | Buy |
40
+11
| +38% | +$15.1K | ﹤0.01% | 6402 |
|
|
2021
Q3 | $44K | Sell |
29
-48
| -62% | -$76.9K | ﹤0.01% | 6640 |
|
|
2021
Q2 | $152K | Sell |
77
-29
| -27% | -$53.1K | ﹤0.01% | 5520 |
|
|
2021
Q1 | $195K | Buy |
106
+101
| +2,020% | +$221K | ﹤0.01% | 5059 |
|
|
2020
Q4 | $10K | Buy |
+5
| New | +$13K | ﹤0.01% | 5785 |
|
Other funds holding HEPA
Group One Trading's HEPA Position: Q2 2025 in Review
Group One Trading sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 4 shares — an estimated $2 sold.
Group One Trading first reported a position in HEPA in Q4 2020 and held it in 18 quarters. The position peaked at $195K in Q1 2021. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.
- Group One Trading reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 4 Hepion Pharmaceuticals shares in Q2 2025, an estimated $2.
- Group One Trading first reported a position in Hepion Pharmaceuticals in Q4 2020 and held it in 18 quarters.
- Group One Trading's Hepion Pharmaceuticals position peaked at $195K in Q1 2021.
- 4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.